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During the month of Iune, 1997, the final month of this contract, Dr. Wei Li continued
his investigation of the "priming" effect of vitamin D 3 on parathyroid hormone (PTH)-induced
elevations in cytosolic free Ca 2÷ in cultured osteoblasts. Unlike the vitamin D steroid, neither
estrogen nor progesterone were either to prime the cells' response to PTH. Wei also
confirmed previous experimental results suggesting that vitamin D_ alone does not change
cytoplasmic Ca 2* levels.
To summarize the progress we made during the period supported by the Round I
contract, we demonstrated for the first time that vitamin D3 influences the effect of PTH on
bone cell calcium ion levels. This is a rapid effect, taking place within seconds/minutes. This
may prove to be a critical contribution to our understanding of bone physiology in that these
two hormones are among the most potent regulators of bone calcium content and of systemic
calcium homeostasis. Together with the data gathered from the study of astronauts exposed to
microgravity for extended periods, these observations suggest the interaction of vitamin D3 and
PTH as a possible therapeutic target in the treatment of bone loss disorders such as
osteoporosis and disuse atrophy. Our findings have been accepted for publication (copy
attached):
Li, W., Karin, N.J. and Farach-Carson, M.C. (1997). 1,25-Dihydroxyvitamin D3 Enhances Parathyroid
Hormone-Induced Increase in Cytosolic Free Calcium in Osteoblastic Cells through a Membrane-Initiated
Pathway. Am. J. Physiol. (in press).
Another result from the Round 1 study was our observation that chronic exposure of
cultured osteob]asts to vitamin D 3 altered the number of voltage-sensitive Ca 2+ channels
expressed. Estrogen treatment yielded a similar result, suggesting that there is overlap in the
mechanismby which these hormones elicit long-term effects on bone cell calcium homeostasis.
https://ntrs.nasa.gov/search.jsp?R=19980002526 2020-06-16T01:37:19+00:00Z
1,25(OH)2D3 enhances PTH-induced Ca 2÷ transients
in preosteoblasts by activating L-type Ca 2+ channels
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Li, Wei, Randall L. Duncan, Norman J. Karin, and
Mary C. Farach-Carson. 1,25(OH)2Ds enhances PTH-
induced Ca 2+ transients in preosteoblasts by activating L-
type Ca 2+ channels. Am. J. Physiol. 273 (Endocrinol. Metab.
36): E599-E605, 1997.--We previously demonstrated electro-
physiologically that 1,25-dihydroxyvitamin D3 [1,25(OH)2Ds]
shi_s the activation threshold of L-type Ca 2+ charmels in
osteoblasts toward the resting potential and prolongs mean
open time. Presently, we used single-cell Ca 2+ imaging to
study the combined effects of 1,25(OH)2D3 and parathyroid
hormone (PTH) during generation of Ca 2+ transients in fura
2-loaded MC3T3-E1 cells. Pretreatment with 1,25(OH)2Ds
concentrations, which alone did not produce Ca 2+ transients,
consistently enhanced Ca 2÷ responses to PTH. Enhancement
was dose dependent over the range of 1 to 10 nM and was
blocked by pretreatment with 5 t_I nitrendipine during
pretreatment. A 1,25(OH)2D3 analog that activates L-type
channels and shi_s their activation threshold also enhanced
PTH responses. In contrast, an analog devoid of membrane
Ca 2+ effectsdid not enhance PTH-induced Ca 2+ transients.
The PTH-induced Ca2+ transientinvolvedactivationof a
dihydropyridine-insensitivecationchannel that was inhib-
itedby Gd 3+.Together,these data suggestthat 1,25(OH)2D3
increasesosteoblastresponsivenessto PTH through rapid
modificationofL-typeCa2+channelgatingproperties,whose
activationenhances Ca2+entrythrough otherchannels such
asthe PTH-responsive,Gd 3+-sensitivecationchannel.
calcitropichormones;vitaminD;bone cells;calciumhomeosta-
sis;parathyroidhormone; 1,25-dihydroxyvitaminDs
BOTH 1,25-DIHYDROXYV1TAMIN Ds [1,25(OH)2Ds] and para-
thyroid hormone (PTH) play fundamental roles in
controlling bone density and systemic Ca 2+ homeosta-
sis. Bone is a major target tissue for PTH and
1,25(OH)2Ds, and cells of the osteoblastic lineage pos-
sess receptors for and respond to both hormones (6, 26).
The secosteroid 1,25(OH)2Ds activates both genomic
and nongenomic (membrane-initiated) pathways in
osteoblastic cells, presumably through separate recep-
tor systems (23). The nuclear vitamin D receptor for
1,25(OH)2D3 (nVDR) is well characterized and has been
the subject of numerous comprehensive reviews (21). In
contrast, the identity of the membrane receptor and its
action in controlling intracellular events remain elu-
sive (22). Our laboratory previously demonstrated,
using electrophysiological recording techniques, that
1,25(OH)2Ds increases osteoblastic plasma membrane
permeability to Ca 2÷ by shifting the threshold of L-type
Ca 2÷ channel activation toward the resting potential
and prolonging the channel mean open time (4). This
phenomenon occurs within milliseconds after addition
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of 1,25(OH)2D3. These observations led us to hypoth-
esize that 1,25(OH)2D3 exerts a "priming" effect on
membrane-initiated Ca 2+ responses to other calcitropic
hormones acting through plasma membrane receptors,
such as PTH (13). These responses generally are coupled
to Ca 2+ release from intracellular stores and to nonse-
lective cation channels in the plasma membrane and
together produce transient elevations in cytosolic free
Ca 2+ (12). An enhancing effect of 1,25(OH)2D3 would be
predicted to augment Ca 2+ signaling in response to
other calcitropic hormones and could be manifested as
an increase in either the magnitude or duration of the
Ca +2 transient.
Synthetic analogs of 1,25(OH)2D3 containing various
structural modifications can stimulate subsets of biologi-
cal activities in target cells. These analogs have been
characterized extensively in several laboratories, includ-
ing our own (reviewed in Ref. 1). Analogs such as
1,24-dihydroxy-22-ene-24-cyclopropyl D3 (code name
BT, also known as calcipotriol) bind well to the nVDR
and selectively activate genomic pathways such as
those that lead to increased transcription of bone
matrix proteins such as osteopontin and osteocalcin
(14). Unlike the parent hormone, 1,25(OH)2Ds, these
analogs produce little or no acute stimulation of Ca 2+
influx at low nanomolar concentrations (14). Other
analogs, in particular those lacking the 1-a-hydroxyl
group, such as analogs 25-hydroxy-16-ene-23-yne-Ds
(code name AT) and 25-hydroxy-23-yne-Ds (code name
Y), lack the ability to bind to the nVDR or initiate
transcription of matrix proteins but readily increase
Ca 2+ influx into osteoblastic cells (16). These latter
analogs also shift the activation threshold for L-type
Ca 2+ channels toward the resting membrane potential
(30). We postulated that these readily distinguishable
activities reflect a pharmacological distinction between
the two receptors for 1,25(OH)2Ds, one nuclear and one
in or near the plasma membrane (14).
In this study, we used a single-cell Ca 2+ imaging
system to examine the interaction of 1,25(OH)2D3 or
two of the previously characterized 1,25(OH)2Ds ana-
logs, AT and BT, with PTH. Specifically, we examined
the potential Ca2+-enhancing effect of the secosteroids
with regard to increases in the concentration of free
intracellular Ca 2+ ([Ca2+]i) induced by PTH in preosteo-
blastic MC3T3-E1 cells loaded with fura 2. A nonfusing,
premyocytic cell line, BCsHI, which expresses
1,25(OH)2D3-responsive L-type plasma membrane Ca 2+
channels at high levels characteristic of excitable tis-
sues (3, 10), was studied for comparative purposes.
The role of Ca 2+ influx through voltage-sensitive Ca 2+
channels present in the plasma membrane in the
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1,25(OH)2D3-enhancement phenomenon was demon-
strated using inhibitors of channel function. Interac-
tion with the GdZ+-inhibitable, mechanosensitive cat-
ion channel found in osteoblasts (12) was also revealed
for the first time.
MATERILALS AND METHODS
Materials. Coverslip tissue culture dishes were obtained
from MatTek (Ashland, M.A). Fura 2-AM, the acetexymethyl
ester of the CaZ+-sensitive fluorescent dye, fura 2, was
purchased from Molecular Probes (Eugene, OR). Thapsigar-
gin was obtained from Calbiochem (La Jolla, CA). Bovine
PTH-(1---34), nitrendipine, Gd z+, and other chemicals were
purchased from Sigma Chemical (St. Louis, MO). 1,25(OH)2D s
was from Biomol Research Laboratories (Plymouth Meeting,
PAL and structural analogs were kindly provided by Dr.
Anthony Norman (University of California at Riverside,
Riverside, CA).
Cell culture. MC3T3-E1 cells, a preosteoblastic line derived
from neonatal mouse calvarial bone, were provided by Dr.
Renny Franceschi and maintained as culture stocks in ascor-
bate-free medium containing 10% fetal bovine serum, as
described previously (15). Growth phase BC3H1 premyocytes
were cultured in Dulbecco's modified Eagle's medium
(DMEM)-Ham's F12 (1:1) medium containing 10% fetal bo-
_ne serum as described (25).Cells were plated onto coversllp
dishes in DMEM containing 10% fetalbovine serum 2 days
before the day of the experiment. All cellswere subconfluent
at the time of the experiments,
Intracellular Ca _+ measurements. We used a single-cell
Ca 2÷ imaging system (Intracellular Imaging, Cincinnati, OH)
to perform intracellular Ca 2+ measurements (28). After the
medium was removed from the dishes, cells were rinsed with
Hanks' balanced salt solution (HBSS) (140 mM NaC1, 4.2 mM
KC1, 0.5 mM NaH2PO4, 0.4 mM NazHPO4, 0.4 mM MgSO4,
0.3 mM MgC12, 1 mM CaC12, 6 mM glucose, 0.1% bovine
serum albumin, and 20 mM N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid, pH 7.4) and then loaded with 3 rum fura
2-AM in HBSS for 30 rain at 37°C. The conditions were chosen
to avoid probe compartmentalization and to maximize cyto-
plasmic dye localization. The loaded cells were incubated
further for 15 rain with HBSS alone to allow the complete
deesterification of fluorescent probe. Fura 2 fluorescence was
visualized with a Nikon inverted microscope using a Nikon
×40 fluor objective. The cells were illuminated with a xenon
lamp equipped with quartz collector lenses. A shutter and
filter changer containing the two different interference filters
(340 and 380 nm) were computer controlled. Emitted light
was passed through a 430-nm dichroie mirror, filtered at 510
nm, and imaged with an integrating charge-coupled device
video camera. Four to eight cells were measured within each
field. Consecutive frames obtained at 340- and 380-urn excita-
tion were compared as a ratio (F34o/Fsso), and [Ca2+]i in each
cell was calculated from F34o/F3so by comparison with fura 2
free acid standards. Individual Ca 2+ traces shown in Figs.
1-4 are computer-generated population means derived from
simultaneous recording of [Ca2+]iin the four to eight single
cellsin a microscopic field.Each experiment was repeated at
least three times, and Figs. I-4 were constructed from
representative experiments.
1,25(OH)2D3 and structuralanalogs. 1,25(OH)2Ds and struc-
tural analogs AT and BT were stored as stock solutions in
absolute ethanol in the dark at -20°C until use. The struc-
tural integrity and concentrations of the compounds were
routinely monitored from the absorption spectra and by
comparison of the absorbency ratio at 264/228 nm, as de-
scribed previously (4). Solutions with a ratio <1.6 were
discarded.
Other methods. Bovine PTH-(1--34) was dissolved in dis-
tilled water. Thapsigargin and nitrendipine were maintained
and dispensed from stock solutions in dimethyl sulfoxide
(DMSO) or absolute ethanol, respectively. All reagents were
stored in the dark at -20°C. The delivery vehicle was used as
the control in all experiments.
RESULTS
1,25(OH)sD 3 enhances PTH-induced increases in cyto-
solic Ca 2+ concentration in preosteoblastic MC3T3-E1
cells. In our initial experiments, we measured the
ability of nanomolar concentrations of 1,25(OH)2D3 to
induce transient rises in [Ca 2÷ ]i in single cells represent-
ing the preosteoblastic and premyocytic phenotypes,
both previously shown to express L-type Ca 2÷ channels
responsive to secosteroids (4, 10, 20). As shown in Fig.
1, exogenously added 1,25(OH)2D3 (10 nM) produced an
immediate and rapid increase of [Ca2+]i in fura-loaded
premyocytic BCsH1 cells (Fig. 1A) but no significant
[Ca 2+ ]i increase in preosteoblastic MC3T3-E 1 cells (Fig.
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Fig. 1. Effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2Ds] on concen-
tration of free intracellular Ca 2+ ([Ca2+]i) in growth phase myocytic
BCsH1 cells and preosteoblastic MC3T3-E1 cells. Measurements of
[Ca2+]i were made using a single-cell Ca 2+ imaging system, as
describedin MATERL_LSAND METHODS.A: BCsHx cells treatedwith 10
nM 1,25(OH)2D3 demonstrate a Ca 2+transientthatpeaks within15 s
and then restsat new baseline.B: MC3T3-E1 cellstreatedwith same
concentrationof 1,25(OH)2D3 do not show a similarCa 2+ transient
but willreleaseCa 2+ from intracellularstoresin response to 5 tim
thapsigargin (TG). First arrow denotes time of addition of
1,25(OH)2Ds.
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1B). The lack of response in MC3T3-E1 cells is not
attributable to an absence of releasable Ca 2+ in intracel-
lular stores, because addition of thapsigargin immedi-
ately produced a Ca 2+ transient (Fig. 1B). Depolariza-
tion of the MC3T3-E1 cells with 60-120 mM
extracellular K ÷ also failed to elicit a Ca 2+ signal
detected by fura 2, although 4SCa2+ influx studies
showed that depolarization triggered an increase in
Ca 2÷ uptake within 2 rain (data not shown). We next
examined the potential ability of 1,25(OH)2D3 to en-
hance PTH effects on [Ca2+]i in MC3T3-E1 preosteo-
blasts, a direct test of our hypothesis that the left shii_
in activation potential toward the resting potential
would augment development of the Ca 2+ transient
induced by PTH. The traces presented in Fig. 2 show
that in MC3T3-E1 cells, pretreatment with 10 nM
1,25(OH)2Ds for 10 min before PTH stimulation (Fig.
2A) enhanced the PTH-induced Ca 2+ transient com-
pared with control pretreatment with vehicle (ethanol)
alone (Fig. 2B). To investigate if influx through L-type
Ca 2+ channels is required for the enhancement effect,
we tested whether inclusion of 5 _M nitrendipine, a
dihydropyridine blocker of L-type Ca 2÷ channels, would
attenuate the enhancement effect of 1,25(OH)2Ds. As
seen in Fig. 2C, the Ca 2+ transient induced by PTH
after treatment with both 1,25(OH)2D3 and nitren-
dipine was comparable to that produced by PTH in cells
treated with vehicle alone (compare Fig. 2, B and C).
Because nitrendipine did not block the PTH-induced
Ca 2+ transient (Fig. 2C), we tested whether this tran-
sient could be blocked by Gd s÷, a lanthanide cation that
inhibits stretch-activated Ca2+-conducting channels
known to be present in osteoblasts (12). As shown in
Fig. 2D, addition of 10 _ Gd 3+ completely abolished
the PTH-induced Ca 2÷ transient, even aider addition of
1,25(OH)2D3. The same effect was seen if the Gd 3÷ was
added during the pretreatment period (data not shown).
Even when intracellular stores were full (Fig. 1B), the
elimination of extracellular Ca 2+ completely abolished
development of the Ca 2+ transient after addition of
1,25(OH)2Ds and PTH, indicating that influx of extracel-
lular Ca 2. was required for development of the Ca 2+
signal in response to PTH (data not shown). The
increased slope after addition of PTH was a common,
but not invariable, occurrence during repetition of
these experiments. At present we have no explanation
for this phenomenon. In further studies, we tested
whether the enhancing effect on PTH-induced influx
through Gd3+-sensitive channels produced by
1,25(OH)2Da was dose dependent. An enhancement of
the PTH-induced increase in [Ca_+]i by pretreatment
with 5 nM 1,25(OH)2D3 was seen, although the magni-
tude of [Ca2+]i rise was less than that induced by
pretreatment with the 10-nM dosage (compare Fig. 3,A
and B). Treatment with 1 nM 1,25(OH)2Ds produced a
barely detectable enhancement of PTH-induced Ca 2+
signals (Fig. 3C). Simultaneous addition of 1,25(OH)2D3
and PTH did not increase the magnitude or duration of
the Ca 2+ transient (data not shown) relative to that
induced by PTH alone.
BCsHz premyocytes did not exhibit Ca 2+ transients in
response to the addition of PTH (data not shown),
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Fig.2.Enhancementofparathyroidhor-
mone (PTH)-stimulatedincreasein
[Ca+2]iby 1,25(OH)$Ds.MC3T3-E1 cells
loadedwithfura2 werepretreatedwith
10nM 1,25(OH)2Ds(A),ethanolvehicle
(B),or10nM 1,25(OH)sDs+ 5_M nitren-
dipine(C)for10rain,attheend ofwhich
timePTH (0.5_M) was added(arrows).
ComparisonofCa2+transientproduced
inA and B demonstratesenhancement
effect,which isblockedby inclusionof
nitrendipine(C).Even after10 rainof
pretreatmentwith 1,25(OH)2D3,PTH-
induced Ca2+ transientis completely
blockedifGds÷(GD;10_tM)isadded(D).
This PTH-induced transientis not
blockedbynitrendipine(C).
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Fig. 3. Ability of 1,25(OH)2Ds to en-
hance PTH-induced Ca2+ currents is 50
dose dependent. MC3T3-E1 cells were
treatedwithvariousconcentrationsof
1,25(OH)2D3fori0rain,thenPTH (0.5 _ 0
t_¢i) was added. Enhancement of PTH-
induced Ca 2+ signal produced by ,=_
1,25(OH)zD3 was dose dependent be- + C
tween 1-10 riM. As shown in Fig. I.B, ¢_ 200
thisconcentrationf1,25(OH)2D3alone _}
didnotproduceaCa2+transient.A, 10
nM 1,25(OH)2Ds;B,5nM 1,25(OH)2D3;
C, 1 nM 1,25(OH)2D3; D, vehicle alone. 150
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presumably because they lack appropriate PTH-respon-
sive receptor systems.
Enhancement of the Ca 2+ transient stimulated by
PTH by pretreatment with analog AT but not analog BT
We used two analogs of 1,25(OH)2Ds that selectively
activate either genomic nVDR-mediated (analog BT) or
nongenomic membrane-initiated Ca2+-signaling path-
ways (analog AT) in osteoblastic cells (14). We tested
the ability of analogs AT and BT to augment the
PTH-induced rise in [Ca2+]i in MC3T3-E1 preosteo-
blasts, analogous to the previous experiments using
1,25(OH)2D3. Pretreatment of cells with analog AT (10
riM) for 10 rain enhanced the Ca 2+ transient produced
by PTH (Fig. 4A), which was not seen with the vehicle
control(Fig.2B). This enhancement by analog AT was
similar in magnitude and duration to that obtained
with the parent compound, 1,25(OH)zD3. Conversely,
pretreatment with analog BT (10 riM) had no effecton
the increase in [Ca2+]i induced by PTH (Fig. 4B).
Neither AT nor BT directlyproduced a risein [Ca2+]iin
MC3T3-E1 cells in the absence of PTH (data not
shown). The inclusion of nitrendipine with analog AT
completely negated the enhancement effect(Fig.4C).
Inclusion of Gd 3+ (Fig.4D) also completely abolished
the response to PTH after pretreatment with analog
AT.
DISCUSSION
1,25(OH)2D3 and PTH are calcitropic hormones that
potentiate long-term regulation of bone structure and
physiology. This control is exerted, at least in part, by
osteoblasts that contain specific receptors for these
circulating hormones (6, 26). In the complex processes
of bone remodeling and Ca 2+ homeostasis, the effects of
each hormone alone and in combination on the activity
of osteoblasts must be considered. In addition to the
well-characterized genomic actions attributed to activa-
tion of nVDRs, 1,25(OH)2D3 also produces rapid changes
in membrane Ca _+ permeability that are independent
of hormonal regulation of gene expression (8, 16). In
thisregard, changes in osteoblastic[Ca2+]i might serve
as signals to regulate systemic Ca 2+ homeostasis by
modulating transfer ofsolublebone Ca 2+ tothe general
extracellularfluid.
Addition of PTH to primary cultures of osteoblasts
(17) or to clonal osteoblast-likeosteosarcoma celllines
(11, 27, 29) elicitsa rapid but transient elevation of
[Ca2+]ithat is generated by influx of Ca 2+ through
plasma membrane channels coupled to release of Ca 2+
from intracellularstores. Furthermore, proliferating
cultures of MC3T3-E1 cellsexpress mRNA encoding
the PTH receptor,the levelsof which increase during
celldifferentiation(18). In differentiated osteoblasts,
1,25(OH)2Ds also induces rapid increases in [Ca2+]iby
stimulation of transmembrane influx combined with
release of Ca 2+ from intracellularstores (8, 17). Ca 2+
influxin response to calcitropicagents can be blocked
by polyvalent transition metal cations and by several
organic Ca 2+ channel antagonists (8, 17) and thus
involvesvoltage-gated Ca 2+ channels. Previous studies
have also demonstrated that osteoblasticcellsexpress
Gd3+-sensitive,stretch-activatedchannels that can be
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Fig. 4. Enhancement of PTH-stimu-
lated increase in [Ca+2]i by analog 25-
hydroxy-16-ene-23-yne-D3 (AT) but not
analog 1,24-dihydroxy-22-ene-24-cyclo-
propyi D3 (BT). MC3T3-E1 cells loaded
with fura 2 were pretreated with 10 nM
analog AT (A) or analog BT (B) or 10
nM AT + 5 _VI nitrendipine (C), after
which time PTH (0.5 pM) was added
(arrows). Effect of AT but not BT was
similar to that of 1,25(OH)_D3. AT-
enhanced, FIq-I-induced transient was
completely abolished in presence of 10
p_M Gd 3 + (D).
stimulated by PTH and provide a large capacitative
entry of extracellular Ca z+ (12).
In this study, neither 1,25(OH)2Ds treatment (10 nM)
nor K + depolarization significantly increased [Ca2+]i in
preosteoblastic MC3T3-E1 cells loaded with fura 2,
even though intracellular stores were filled. In con-
trast, an immediate and rapid increase in [Ca2+]i was
produced by addition of 1,25(OH)2Ds to BCsH1 premyo-
cytic cells. In previous studies, single-channel measure-
ments performed using a patch clamp revealed that
osteosarcoma cells possess about 1-2 x 103 functional
L-type Ca 2+ channels per cell (4). In comparison, differ-
entiated clonal BCsH1 myocytes express 1-2 x 104 Ca 2+
channels per cell (2, 25). The very different density of
functional Ca 2+ channels in the plasma membranes of
BCsH1 myocytes and MC3T3-E1 cells may account for
the differences in the response of these two cell types to
1,25(OH)2D3 that we report in Fig. 1. These observa-
tions are consistent with the origin of these cell lines in
tissues considered to be _excitable" and _nonexcitable,"
respectively, in which only the former are believed to
possess the machinery involved in Ca2+-induced Ca 2+
release from intracellular stores (9). Supporting this,
we previously reported that UMR-106 osteosarcoma
cells have no detectable Ca2+-induced Ca 2+ release (19),
assessed by insensitivity to treatment with caffeine. In
multiple experiments with fura 2-loaded cells, we were
unable to detect transient increases in [Ca2+]i in prolif-
erating MC3T3-E1 cells treated with 1,25(OH)2Ds alone
or subjected to K ÷ depolarization. In contrast, Oshima
et al. (24) reported transient elevations in [Ca2+]i in
response to 1,25(OH)2D3 but not 24,25(OH)2Ds. We
believe that this difference reflects a greater state of
differentiation in their MC3T3-E1 cultures, which were
first grown to confluence, subcultured, then withdrawn
from the cell cycle by transfer to low serum medium. We
previously found that the steady-state levels of mRNA-
encoding L-type Ca 2+ channels in MC3T3-E1 cells
increase substantially during differentiation (20), and
it is possible that other systems involved in Ca 2+-
induced release of Ca 2+ from stores or regulating Ca 2+
influx are similarly upregulated.
Earlier studies showed that cells derived from neona-
tal rat calvaria possess two classes of voltage-gated
Ca _+ channels of the _low threshold" (T-type) and _high
threshold" (L-type) (7), the latter identified by their
sensitivity to organic Ca 2+ channel antagonists, in
particular the dihydropyridines. In a previous study
(4), our laboratory demonstrated, using single channel
recording techniques, that osteoblastic osteosarcoma
cells express L-type but not T-type Ca 2+ channels that
respond both to dihydropyridine agonists, such as BAY
K 8644, and antagonists, such as nitrendipine. Addition-
ally, we found that, within milliseconds of addition of
1,25(OH)2D3, there consistently occurred a shift in the
threshold of activation of inward L-type Ca 2÷ currents
to more negative and near-resting potentials, which
single-channel analysis revealed was accompanied by a
prolonged open time of individual channels (4). On the
basis of these findings, we predicted that this shift in
the activation threshold would result in an increased
responsiveness to other calcitropic hormones, such as
PTH, that als0 activate plasma membrane Ca 2+ influx
through voltage-insensitive channels (12, 13). In this
report, we show that in MC3T3-E1 cells, PTH alone
stimulates only a modest increase in [Ca2*]i. However,
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pretreatment with 1,25(OH)2D3 for i0 min dramati-
cally enhanced the PTH-induced Ca 2+ transient, clearly
indicating that 1,25(OH)2D3 served a priming function
to enhance Ca 2+ responsiveness at the level of the
plasma membrane. The need for preincubation with
1,25(OH)2D3 suggests the existence of intracellular
pathways involving second messengers, which take
minutes to transmit the signal to the PTH-response
system. The block of activation by removal of extracellu-
lar Ca 2+ or addition of dihydropyridine channel block-
ers indicates that enhancement of the PTH response
absolutely depends on the presence and influx of extra-
cellular Ca 2÷ through L-type channels.
We previously measured the ability of structural
analogs of 1,25(OH)2Ds to stimulate various genomic
and plasma membrane-initiated events (14). Although
1,25(OH)2Ds functions as the natural ligand for initia-
tion of both long-term and rapid responses in target
cells, we identified subsets of response pathways that
were activated by discrete structural analogs. Analog
AT activates Ca 2÷ channels in plasma membranes
without binding to nVDRs, whereas analog BT binds
the nVDR for 1,25(OH)2D3 without triggering a measur-
able influx of extracellular Ca 2÷. We examined the
effects of analogs AT and BT alone and in combination
with PTH on regulation of [Ca2+]i in MC3T3-E1 cells.
Neither AT nor BT alone increased [Ca 2÷ ]i in M C3T3-E 1
cells. However, pretreatment with analog AT enhanced
the transient rise in [Ca2+]i stimulated by PTH, consis-
tent with the shift in the threshold of L-type channel
activation toward the resting potential ("left shift ")
reported for this analog in previous studies (30). Unlike
analog AT, analog BT did not enhance the PTH-induced
elevation in [Ca2+]i. This also is consistent with the
inability of this nVDR-selective analog to produce a left
shift in the activation threshold at the low nanomolar
concentrations used in these studies (30).
Taken together, these data strongly support our
hypothesis that 1,25(OH)2Ds and Ca2÷-activating ana-
logs serve a priming function by activating plasma
membrane voltage-sensitive Ca 2÷ channels. One inter-
pretation of these findings is that voltage-sensitive
Ca 2+ channel activation is required for subsequent full
activation of the Gd2+-sensitive channel by PTH, since
nitrendipine addition eliminated the enhancement of
PTH-sensitive Ca 2+ influx. A second possibility is that
the Gd3+-sensitive channel and the L-type channel
must both be activated to generate sufficient depolariza-
tion of the plasma membrane to permit development of
a large Ca 2+ transient. In either case, these data
indicate the existence of an additional level of interac-
tion of these hormones separate from the previously
characterized genomic regulatory loops (5). We believe
that this previously unappreciated and novel action of
1,25(OH)2Ds may facilitate the action of other hor-
mones and growth factors acting on osteoblasts and
could explain some of the seemingly contradictory
physiological effects of 1,25(OH)2D3. It will be of inter-
est to elucidate the mechanism by which Ca 2+ influx
through L-type channels in the plasma membrane is
linked to release of Ca e+ from intracellular Ca 2. stores
in osteoblasts and to influx through voltage-insensitive
Ca 2+ channels.
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